Optimal detection of hypothyroidism in early stage laryngeal cancer treated with radiotherapy

Journal of Otolaryngology-Head & Neck Surgery

Jeffrey R. Harris²  Vincent L. Biron²  Daniel O’Connell²  Hadi Seikaly²  Nicholas Tkacyzk¹  Nhu-Tram A. Nguyen³  Han Zhang²  Graeme B. Mulholland² 

[1] Northern Ontario School of Medicine, Sudbury, Canada;Division of Otolaryngology-Head and Neck Surgery, University of Alberta Hospital, 1E4.29 WMC, 8440 – 112 Street, Edmonton T6G 2B7, AB, Canada;Division of Radiation Oncology, McMaster University, Hamilton, Canada

关键词: Radiation therapy;    Early stage laryngeal squamous cell carcinoma;    Hypothyroidism;   

Others  :  1224826
DOI  :  10.1186/s40463-015-0085-3

 received in 2015-06-06, accepted in 2015-08-24,  发布年份 2015

【 摘 要 】

Background

Hypothyroidism following radiation therapy (RT) for treatment of Head and Neck Cancer (HNC) is a common occurrence. Rates of hypothyroidism following RT for Early Stage Laryngeal Squamous Cell Carcinoma (ES-LSCC) are among the highest. Although routine screening for hypothyroidism is recommended; its optimal schedule has not yet been established. We aim to determine the prevalence and optimal timing of testing for hypothyroidism in ES-LSCC treated with RT.

Method

We conducted a population-based cohort study. Data was extracted from a prospective provincial head and neck cancer database. Demographic, survival data, and pre- and post-treatment thyroid stimulating hormone (TSH) levels were obtained for patients diagnosed with ES-LSCC from 2008–2012. Inclusion criteria consisted of patients diagnosed clinically with ES-LSCC (T1 or 2, N0, M0) treated with curative intent. Patients were excluded if there was a history of hypothyroidism before the treatment or any previous history of head and neck cancers.

Results

Ninety-five patients were included in this study. Mean age was 66.1 years (range: 44.0–88.0 years) and 82.3 % of patients were male. Glottis was the most common subsite at 77.9 % and the average follow-up was 40 months (Range: 12–56 months). Five-year overall survival generated using the Kaplan-Meier method was 79 %. Incidence of hypothyroidism after RT was found to be 46.9 %. The greatest frequency of developing hypothyroidism was at 12 months.

Conclusions

We found a high prevalence of hypothyroidism for ES-LSCC treated with RT, with the highest rate at 12 months. Consequently, we recommend possible routine screening for hypothyroidism using TSH level starting at 12 months. To our knowledge, this is the first study to suggest the optimal timing for the detection of hypothyroidism.

【 授权许可】

   
2015 Mulholland et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

【 参考文献 】

• [1]Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65(1):5-29.
• [2]Canadian Cancer Society statistics. 2013. Available at: http://www.cancer.ca/en/cancer-information/cancer-type/laryngeal/statistics/?region=ab (accessed on February, 2015).
• [3]Makki FM, Williams B, Rajaraman M, Hart RD, Trites J, Brown T et al.. Current practice patterns in the management of glottic cancer in canada: results of a national survey. J Otolaryngol Head Neck Surg. 2011; 40(3):205-210.
• [4]Taylor SM, Kerr P, Fung K, Aneeshkumar MK, Wilke D, Jiang Y et al.. Treatment of T1b glottic SCC: Laser vs. radiation—a canadian multicenter study. J Otolaryngol Head Neck Surg. 2013; 42:22-0216-42-22. BioMed Central Full Text
• [5]Chera BS, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys. 2010; 78(2):461-466.
• [6]Gupta T, Agarwal J, Jain S, Phurailatpam R, Kannan S, Ghosh-Laskar S et al.. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. Radiother Oncol. 2012; 104:343.
• [7]Miller MC, Agrawal A. Hypothyroidism in postradiation head and neck cancer patients: incidence, complications, and management. Curr Opin Otolaryngol Head Neck Surg. 2009; 17(2):111-115.
• [8]Kumpulainen EJ, Hirvikoski PP, Virtaniemi JA, Johansson RT, Simonen PM, Terävä MT et al.. Hypothyroidism after radiotherapy for laryngeal cancer. Radiother Oncol. 2000; 57(1):97-101.
• [9]Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI et al.. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012; 18:988-1028.
• [10]Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004; 291:228-238.
• [11]Pfister DG, Spencer S, Brizel DM, Burtness BA, Busse PM, Caudell JJ  et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Head and Neck Cancers. 2nd ed. Washington, PA: National Comprehensive Cancer Network; 2014.
• [12]Edge SB. AJCC cancer staging handbook: from the AJCC cancer staging manual. 7th ed. Springer, New York; 2010.
• [13]Alberta Heath Services. Cancer Available at: http://www.albertahealthservices.ca/2171.asp (accessed March 1, 2013).
• [14]Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40:373-383.
• [15]Mercado G, Adelstein DJ, Saxton JP, Secic M, Larto MA, Lavertu P. Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer. 2001; 92(11):2892-2897.
• [16]Sinard RJ, Tobin EJ, Mazzaferri EL, Hodgson SE, Young DC, Kunz AL et al.. Hypothyroidism after treatment for nonthyroid head and neck cancer. Arch Otolaryngol Head Neck Surg. 2000; 126(5):652-657.
• [17]Boomsma MJ, Bijl HP, Langendijk JA. Radiation-induced hypothyroidism in head and neck cancer patients: a systematic review. Radiother Oncol. 2011; 99(1):1-5.
• [18]Kumar S, Moorthy R, Dhanasekar G, Thompson S, Griffiths H. The incidence of thyroid dysfunction following radiotherapy for early stage carcinoma of the larynx. Eur Arch Otorhinolaryngol. 2011; 268(10):1519-1522.
• [19]Kaptein EM, LoPresti JS, Kaptein MJ. Is an isolated TSH elevation in chronic nonthyroidal illness “subclinical hypothyroidism”? J Clin Endocrinol Metab. 2014; 99(11):4015-4026.
• [20]Murthy V, Narang K, Ghosh-Laskar S, Gupta T, Budrukkar A, Agrawal JP. Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: Prospective data from 2 randomized controlled trials. Head Neck. 2014; 36(11):1573-1580.